HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Marc Miravitlles Selected Research

moxifloxacin (Avelox)

1/2015Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD.
7/2012Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results.
1/2011A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology.
1/2010Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial.
1/2010Antibiotic treatment of exacerbations of COPD in general practice: long-term impact on health-related quality of life.
12/2009Characterisation of exacerbations of chronic bronchitis and COPD in Europe: the GIANT study.
7/2008Moxifloxacin: a respiratory fluoroquinolone.
1/2007Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD.
1/2007[Clinical efficacy of moxifloxacin in the treatment of exacerbations of chronic bronchitis: a systematic review and meta-analysis].
1/2007Determining factors in the prescription of moxifloxacin in exacerbations of chronic bronchitis in the primary-care setting.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Marc Miravitlles Research Topics

Disease

65Chronic Obstructive Pulmonary Disease (COPD)
10/2015 - 09/2002
10Chronic Bronchitis
06/2013 - 02/2005
7Respiratory Tract Infections (Respiratory Tract Infection)
03/2013 - 02/2005
5Asthma (Bronchial Asthma)
01/2015 - 06/2013
4Emphysema
08/2015 - 02/2008
4Pneumonia (Pneumonitis)
06/2015 - 02/2005
4Infection
06/2015 - 12/2005
4Dyspnea (Shortness of Breath)
01/2014 - 04/2006
3Bronchitis
10/2014 - 01/2011
2Respiratory Sounds (Crackle)
01/2015 - 06/2012
2Bronchiectasis
12/2013 - 01/2005
2Cough
01/2013 - 12/2007
1Eosinophilia
01/2015
1Lung Diseases (Lung Disease)
01/2015
1Inflammation
01/2015
1Cardiovascular Diseases (Cardiovascular Disease)
01/2014
1Bacterial Infections (Bacterial Infection)
12/2013
1Cystic Fibrosis (Mucoviscidosis)
12/2013
1Obstructive Lung Diseases (Obstructive Lung Disease)
06/2013
1Pneumococcal Infections
01/2013
1Heart Failure
08/2012
1Dementia (Dementias)
08/2012
1Airway Obstruction (Choking)
12/2006
1Tonsillitis
12/2005
1Otitis Media
01/2005
1Pulmonary Emphysema
07/2003

Drug/Important Bio-Agent (IBA)

15Anti-Bacterial Agents (Antibiotics)IBA
10/2014 - 03/2004
12Adrenal Cortex Hormones (Corticosteroids)IBA
06/2015 - 04/2006
12moxifloxacin (Avelox)FDA Link
01/2015 - 01/2003
11GoldIBA
06/2015 - 04/2006
6Bronchodilator Agents (Bronchodilators)IBA
06/2015 - 12/2006
6AAT deficiencyIBA
04/2015 - 07/2003
5Carbon MonoxideIBA
08/2015 - 08/2004
5tiotropium (Spiriva)FDA Link
01/2015 - 06/2007
5Amoxicillin (Wymox)FDA LinkGeneric
11/2013 - 01/2009
4C-Reactive ProteinIBA
05/2015 - 12/2010
4Clavulanic Acid (Potassium Clavulanate)FDA LinkGeneric
11/2013 - 01/2009
3formoterol (Oxis)FDA Link
10/2015 - 10/2009
3Biological Markers (Surrogate Marker)IBA
08/2013 - 01/2010
3Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)FDA Link
01/2013 - 01/2011
2Budesonide (Pulmicort)FDA LinkGeneric
08/2015 - 10/2009
2Anti-Inflammatory Agents (Anti-Inflammatories)IBA
06/2015 - 06/2005
2SmokeIBA
06/2013 - 06/2006
2Penicillin V (Phenoxymethylpenicillin)FDA LinkGeneric
01/2013 - 12/2005
2Penicillins (Penicillin)FDA Link
01/2013 - 12/2005
2MacrolidesIBA
02/2009 - 01/2007
2Immunoferon (AM3)IBA
05/2008 - 04/2005
15- (2- (5,6- diethylindan- 2- ylamino)- 1- hydroxyethyl)- 8- hydroxy- 1H- quinolin- 2- oneIBA
10/2015
1(3R)- 3- ((hydroxy(di- 2- thienyl)acetyl)oxy)- 1- (3- phenoxypropyl)- 1- azoniabicyclo(2.2.2)octane bromideIBA
10/2015
14- (2- ((6- ((2- (((2,6- dichlorophenyl)methyl)oxy)ethyl)oxy)hexyl)amino)- 1- hydroxyethyl)- 2- (hydroxymethyl)phenolIBA
10/2015
1Inflammation MediatorsIBA
01/2015
1Immunoglobulin E (IgE)IBA
01/2015
1beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA
08/2013
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
06/2013
1Ibuprofen (Motrin)FDA LinkGeneric
01/2013
1OxygenIBA
08/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2010
1Interleukin-8 (Interleukin 8)IBA
01/2010
1Fibrinogen (Factor I)FDA Link
01/2010
1Interleukin-6 (Interleukin 6)IBA
01/2010
1QuinolonesIBA
02/2009
1SteroidsIBA
12/2007
1Ipratropium (Ipratropium Bromide)FDA LinkGeneric
06/2007
1salmeterol (Serevent)FDA Link
06/2007
1Phosphodiesterase 4 InhibitorsIBA
06/2005
1Glutathione Transferase (Glutathione S-Transferase)IBA
05/2005
1Immunoglobulin G (IgG)IBA
01/2005
1AntibodiesIBA
01/2005
1Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA
01/2005
1Epoxide HydrolasesIBA
09/2002
1DNA (Deoxyribonucleic Acid)IBA
09/2002

Therapy/Procedure

2Antibiotic Prophylaxis
06/2015 - 12/2013
2Activities of Daily Living (ADL)
06/2012 - 02/2007
2Aftercare (After-Treatment)
05/2011 - 01/2003
1Nebulizers and Vaporizers (Inhaler)
10/2015
1Transplants (Transplant)
08/2015
1Lung Transplantation
08/2015
1Individualized Medicine
12/2014
1Artificial Respiration (Mechanical Ventilation)
01/2012
1Drug Therapy (Chemotherapy)
01/2009